Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trial.

Sen A. et al, (2024), Epilepsia Open

Artificial intelligence and cybercrime: implications for individuals and the healthcare sector.

Monteith S. et al, (2024), Br J Psychiatry, 1 - 3

Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.

Taquet M. et al, (2024), Lancet Psychiatry

Implications of Online Self-Diagnosis in Psychiatry.

Monteith S. et al, (2024), Pharmacopsychiatry, 57, 45 - 52

Co-design of 'Ways of Being', a web-based experience to optimise online arts and culture for mental health in young people.

Syed Sheriff RJ. et al, (2024), BJPsych Bull, 1 - 8

Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study

Elneima O. et al, (2024), International Journal of Epidemiology, 53

Violence in schizophrenia: triangulating the evidence on perpetration risk

Whiting D. et al, (2024), World Psychiatry, 23, 158 - 160

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.

Taquet M. et al, (2024), Brain Commun, 6

One year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study

Leavy OC. et al, (2023)

Individual-level risk factors for suicide mortality in the general population: an umbrella review.

Favril L. et al, (2023), Lancet Public Health, 8, e868 - e877

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.

C-MORE/PHOSP-COVID Collaborative Group None., (2023), Lancet Respir Med, 11, 1003 - 1019

Artificial intelligence and increasing misinformation.

Monteith S. et al, (2023), Br J Psychiatry, 1 - 3

Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.

Taquet M. et al, (2023), Nat Med, 29, 2498 - 2508

Count Me In: an inclusive approach towards patient recruitment for clinical research studies in the NHS.

Hinze V. et al, (2023), BMJ Ment Health, 26

Challenges and Ethical Considerations to Successfully Implement Artificial Intelligence in Clinical Medicine and Neuroscience: a Narrative Review.

Monteith S. et al, (2023), Pharmacopsychiatry

Telepsychiatry in an Era of Digital Mental Health Startups.

Achtyes ED. et al, (2023), Curr Psychiatry Rep, 25, 263 - 272

Technology exceptionalism in medicine: Is it time to rethink the paradigm?

Achtyes E. et al, (2023), Eur Neuropsychopharmacol, 74, 30 - 31

Cohort Profile: Post-hospitalisation COVID-19 study (PHOSP-COVID)

Elneima O. et al, (2023)

Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST).

Winter-van Rossum I. et al, (2023), Lancet Psychiatry, 10, 197 - 208

User perspectives on long-term remote active electronic self-monitoring of mood symptoms in bipolar spectrum disorders.

Gordon-Smith K. et al, (2023), J Affect Disord, 324, 325 - 333

Load More

Include forthcoming?